Literature DB >> 3355557

cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis.

K Kadomatsu1, M Tomomura, T Muramatsu.   

Abstract

By the differential hybridization technique, we isolated a cDNA clone, MK1, whose RNA level increased in early stages of retinoic acid-induced differentiation of embryonal carcinoma cells. The amount of MK1 RNA progressively decreased in the later stages of the differentiation. In mouse embryos, MK1 RNA was abundant in mid-gestation stages (Day 8 to Day 11) and decreased thereafter. The corresponding RNA was 1.0 killobase in size. From the nucleotide sequence, MK1 gene was predicted to code a polypeptide of molecular weight 9,971, which was rich in basic amino acids.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3355557     DOI: 10.1016/s0006-291x(88)80505-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  104 in total

1.  Nuclear targeting by the growth factor midkine.

Authors:  Yoshihisa Shibata; Takashi Muramatsu; Makoto Hirai; Tatsuya Inui; Terutoshi Kimura; Hidehiko Saito; Lynn M McCormick; Guojun Bu; Kenji Kadomatsu
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

2.  Midkine and pleiotrophin have bactericidal properties: preserved antibacterial activity in a family of heparin-binding growth factors during evolution.

Authors:  Sara L Svensson; Mukesh Pasupuleti; Björn Walse; Martin Malmsten; Matthias Mörgelin; Camilla Sjögren; Anders I Olin; Mattias Collin; Artur Schmidtchen; Ruth Palmer; Arne Egesten
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

Review 3.  Structure and function of midkine as the basis of its pharmacological effects.

Authors:  T Muramatsu
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 4.  The midkine family of growth factors: diverse roles in nervous system formation and maintenance.

Authors:  C Winkler; S Yao
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

5.  Localization and ontogeny of the orphan receptor OR-1 in the rat brain.

Authors:  T Kainu; J Kononen; E Enmark; J A Gustafsson; M Pelto-Huikko
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

6.  Midkine is expressed and differentially processed during chronic obstructive pulmonary disease exacerbations and ventilator-associated pneumonia associated with Staphylococcus aureus infection.

Authors:  Helena M Linge; Cecilia Andersson; Sara L Nordin; Anders I Olin; Ann-Cathrine Petersson; Matthias Mörgelin; Amanda Welin; Johan Bylund; Leif Bjermer; Jonas Erjefält; Arne Egesten
Journal:  Mol Med       Date:  2013-09-30       Impact factor: 6.354

7.  Midkine mRNA level in peripheral blood mononuclear cells is a novel biomarker for primary non-small cell lung cancer: a prospective study.

Authors:  Zhihong Ma; Hongwei Li; Bin Wang; Qibin Shen; Enhai Cui; Lishan Min; Fuchu Qian; Jinliang Ping; Licheng Dai
Journal:  J Cancer Res Clin Oncol       Date:  2012-12-07       Impact factor: 4.553

Review 8.  Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.

Authors:  D R Jones
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

9.  Midkine, heparin-binding growth factor, blocks kainic acid-induced seizure and neuronal cell death in mouse hippocampus.

Authors:  Yun B Kim; Jae K Ryu; Hong J Lee; In J Lim; Dongsun Park; Min C Lee; Seung U Kim
Journal:  BMC Neurosci       Date:  2010-03-26       Impact factor: 3.288

Review 10.  The role of pleiotrophin and beta-catenin in fetal lung development.

Authors:  Tingting Weng; Lin Liu
Journal:  Respir Res       Date:  2010-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.